ArticleJournal of family medicine and primary care2026
Assessment of cognition and molecular markers for neuropsychological functions in hypertension.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Hypertension is one of the most common reasons for patients to visit family physicians and disrupts cerebral microcirculation, leading to cognitive decline. While its impact on cognition is known, underlying electrophysiological and molecular mechanisms remain unexplored. Aim: This study hypothesizes that assessing molecular markers (NF-κB and Nrf-2) alongside event-related potentials (ERPs) and memory will enhance early detection and intervention, and improve our understanding of hypertension-induced neurocognitive impairment. Settings and Design: A total of 30 hypertensive patients (aged 30-59 years, diagnosed for 2-5 years with Grade 1 or 2 hypertension) and 30 age-matched controls were included in this cross-sectional study between May 2023 and November 2024. Method: Cognition was assessed using auditory ERP and the Post-Graduate Institute Memory Scale. Molecular markers were evaluated using real-time polymerase chain reaction. Statistical Analysis: Unpaired Results: Hypertensive individuals exhibited prolonged P300 latency ( Conclusions: Hypertension may impair cognition, shown by prolonged P300 latency and elevated NF-κB levels. Their positive correlation suggests inflammation slows processing. Higher NF-κB linked to better mental balance may reflect adaptation, but its negative correlation with retention of dissimilar pairs with memory retention suggests neuroinflammation adversely affects specific cognitive functions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.